SG Americas Securities’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,811
Closed -$61K 3409
2024
Q1
$61K Sell
23,811
-15,279
-39% -$37.3K ﹤0.01% 2705
2023
Q4
$80K Sell
39,090
-3,150
-7% -$5.75K ﹤0.01% 2829
2023
Q3
$73K Buy
+42,240
New +$75K ﹤0.01% 2869
2022
Q1
Sell
-10,669
Closed -$137K 3550
2021
Q4
$137K Sell
10,669
-13,628
-56% -$151K ﹤0.01% 2881
2021
Q3
$262K Buy
+24,297
New +$221K ﹤0.01% 3040
2020
Q3
Sell
-16,264
Closed -$108K 3585
2020
Q2
$108K Buy
+16,264
New +$110K ﹤0.01% 3322

Other funds holding GRTS

SG Americas Securities's GRTS Position: Q2 2024 in Review

SG Americas Securities sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 23,811 shares — an estimated $61K sold.

SG Americas Securities first reported a position in GRTS in Q2 2020 and held it in 6 quarters. The position peaked at $262K in Q3 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • SG Americas Securities reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 23,811 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $61K.
  • SG Americas Securities first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • SG Americas Securities's Gritstone bio, Inc. Common Stock position peaked at $262K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.